ATE492282T1 - Zusammensetzung aus steroiden mit transporterweiterter corticosteroid-aktivität - Google Patents
Zusammensetzung aus steroiden mit transporterweiterter corticosteroid-aktivitätInfo
- Publication number
- ATE492282T1 ATE492282T1 AT07795241T AT07795241T ATE492282T1 AT E492282 T1 ATE492282 T1 AT E492282T1 AT 07795241 T AT07795241 T AT 07795241T AT 07795241 T AT07795241 T AT 07795241T AT E492282 T1 ATE492282 T1 AT E492282T1
- Authority
- AT
- Austria
- Prior art keywords
- steroids
- transporter
- advanced
- composition
- activity
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000003431 steroids Chemical group 0.000 title abstract 2
- 239000003246 corticosteroid Substances 0.000 title 1
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 abstract 2
- 230000002708 enhancing effect Effects 0.000 abstract 2
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- -1 cyclopentylethyl Chemical group 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- DMKSVUSAATWOCU-HROMYWEYSA-N loteprednol etabonate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)OCCl)(OC(=O)OCC)[C@@]1(C)C[C@@H]2O DMKSVUSAATWOCU-HROMYWEYSA-N 0.000 abstract 1
- 229960003744 loteprednol etabonate Drugs 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80811806P | 2006-05-25 | 2006-05-25 | |
| PCT/US2007/012304 WO2007142842A2 (en) | 2006-05-25 | 2007-05-24 | Combination of anti-inflammatory steroids having transporter-enhanced corticosteroid activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE492282T1 true ATE492282T1 (de) | 2011-01-15 |
Family
ID=38801975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07795241T ATE492282T1 (de) | 2006-05-25 | 2007-05-24 | Zusammensetzung aus steroiden mit transporterweiterter corticosteroid-aktivität |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7687484B2 (de) |
| EP (1) | EP2026818B1 (de) |
| JP (1) | JP5278313B2 (de) |
| AT (1) | ATE492282T1 (de) |
| CA (1) | CA2653206C (de) |
| DE (1) | DE602007011431D1 (de) |
| ES (1) | ES2356946T3 (de) |
| WO (1) | WO2007142842A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8835410B2 (en) | 2011-05-10 | 2014-09-16 | Bodor Laboratories, Inc. | Treatment of eyelid dermatitis |
| UA116622C2 (uk) * | 2011-11-11 | 2018-04-25 | Аллерган, Інк. | Похідні 4-прегенен-11ss-17-21-тріол-3,20-діону для лікування хвороб очей |
| EP3006453A1 (de) | 2014-10-08 | 2016-04-13 | Cosmo Technologies Ltd. | 17alpha-Monoester und 17alpha,21-Diester von Cortodoxon zur Verwendung bei der Behandlung von Tumoren |
| ES2905445T3 (es) * | 2016-10-21 | 2022-04-08 | Crescita Therapeutics Inc | Composiciones farmacéuticas |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20551A (en) * | 1858-06-15 | Improvement in hay and cotton presses | ||
| US26892A (en) * | 1860-01-24 | Machine fob grinding | ||
| GB1384372A (en) | 1971-01-20 | 1975-02-19 | Glaxo Lab Ltd | Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids |
| US3828080A (en) | 1972-01-20 | 1974-08-06 | Glaxo Lab Ltd | Androstane-17beta-carboxylic acids and processes for the preparation thereof |
| CH628355A5 (de) | 1976-02-24 | 1982-02-26 | Ciba Geigy Ag | Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze. |
| SE449106B (sv) * | 1980-07-10 | 1987-04-06 | Otsuka Pharma Co Ltd | Steroid med anti-inflammatorisk verkan samt komposition innehallande denna |
| US4996335A (en) | 1980-07-10 | 1991-02-26 | Nicholas S. Bodor | Soft steroids having anti-inflammatory activity |
| ZA814440B (en) * | 1980-07-10 | 1982-10-27 | Otsuka Pharma Co Ltd | Soft steroids having anti-inflammatory activity |
| US4710495A (en) | 1980-07-10 | 1987-12-01 | Otsuka Pharmaceutical Co., Ltd. | Soft steroids having anti-inflammatory activity |
| US5981517A (en) | 1996-05-09 | 1999-11-09 | Soft Drugs, Inc. | Androstene derivatives |
| TW503113B (en) | 1997-01-16 | 2002-09-21 | Senju Pharma Co | Aqueous suspension for nasal administration |
| KR100508227B1 (ko) | 1997-03-14 | 2006-03-23 | 센주 세이야꾸 가부시키가이샤 | 로테프레드놀에타보네이트수성현탁액 |
| EP1339438B1 (de) * | 2000-11-29 | 2005-10-19 | Allergan Inc. | Verhinderung von transplantatabstossung im auge |
| PL369960A1 (en) * | 2001-10-11 | 2005-05-02 | Alcon, Inc. | Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue |
| WO2005000317A1 (en) | 2003-06-19 | 2005-01-06 | Bodor Nicholas S | Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application |
| DE602004008083T2 (de) | 2003-06-19 | 2008-04-24 | Nicholas S. Gainsville Bodor | Verstärkung der aktivität und/oder wirkdauer von ausgewählten entzündungshemmenden steroiden |
-
2007
- 2007-05-22 US US11/802,403 patent/US7687484B2/en active Active
- 2007-05-24 ES ES07795241T patent/ES2356946T3/es active Active
- 2007-05-24 JP JP2009512129A patent/JP5278313B2/ja not_active Expired - Fee Related
- 2007-05-24 AT AT07795241T patent/ATE492282T1/de not_active IP Right Cessation
- 2007-05-24 CA CA2653206A patent/CA2653206C/en active Active
- 2007-05-24 DE DE602007011431T patent/DE602007011431D1/de active Active
- 2007-05-24 EP EP07795241A patent/EP2026818B1/de not_active Not-in-force
- 2007-05-24 WO PCT/US2007/012304 patent/WO2007142842A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2026818A2 (de) | 2009-02-25 |
| CA2653206C (en) | 2014-09-23 |
| WO2007142842A3 (en) | 2008-04-10 |
| DE602007011431D1 (de) | 2011-02-03 |
| ES2356946T3 (es) | 2011-04-14 |
| JP2009538313A (ja) | 2009-11-05 |
| EP2026818B1 (de) | 2010-12-22 |
| WO2007142842A2 (en) | 2007-12-13 |
| CA2653206A1 (en) | 2007-12-13 |
| JP5278313B2 (ja) | 2013-09-04 |
| US7687484B2 (en) | 2010-03-30 |
| US20080004246A1 (en) | 2008-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE454154T1 (de) | Steigerung der aktivität und/oder der wirkungsdauer weicher steroide mit anti- entzündungswirkung für topische oder lokale verabreichung | |
| CR10192A (es) | Compuestos de amido y su uso como productos farmaceuticos | |
| WO2012083112A3 (en) | C- 17 -heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21 | |
| ATE517435T1 (de) | Feldeffekttransistor | |
| MX2009001763A (es) | Tratamiento combinado para trastornos metabolicos. | |
| EA200900635A1 (ru) | Антагонисты прогестеронового рецептора | |
| SG10201809895YA (en) | Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) | |
| PE20081365A1 (es) | Formulaciones topicas para administracion local que contienen indoxacarb | |
| AR085153A1 (es) | Composiciones pesticidas y procesos relacionados | |
| ATE492282T1 (de) | Zusammensetzung aus steroiden mit transporterweiterter corticosteroid-aktivität | |
| DOP2007000028A (es) | Composiciones de ramnolípidos y métodos relacionados con su uso | |
| AR075701A1 (es) | Composicion de control de plagas | |
| MY157397A (en) | Hard fat | |
| PE20171433A1 (es) | Nueva triterpenona c-3 con derivados de amida inversa c-17 como inhibidores de vih | |
| CY1111128T1 (el) | Στεροειδη παραγωγα 17-φωσφορου χρησιμα ως τροποποιητες υποδοχεων προγεστερονης | |
| AR081768A1 (es) | Composiciones pesticidas | |
| AR083146A1 (es) | Composicion de control de fitoenfermedades y su uso | |
| PA8629201A1 (es) | Polimorfo cristalino de acetato de bazedoxifeno | |
| UA105022C2 (uk) | Композиція для боротьби з хворобами рослин та спосіб боротьби з хворобами рослин | |
| DE602004026558D1 (de) | Selektive nichtsteroidale glucocorticoid-rezeptor- modulatoren | |
| CL2010001566A1 (es) | Compuesto derivado de piperidinilo, modulador de la actividad de los receptores de la quimiocina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades inflamatorias, alergicas, autoinmune. | |
| NI200700299A (es) | Composicion de liberación modificada de al menos una forma de venlafaxina | |
| MX347414B (es) | Aldehidos como ingredientes perfumantes. | |
| ATE369138T1 (de) | Verstärkung der aktivität und/oder wirkdauer von ausgewählten entzündungshemmenden steroiden | |
| MX2010004768A (es) | Nitrilos de octan(eno) sustituidos, metodos para la sintesis de los mismos y sus aplicaciones en perfumeria. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |